E-Book | September 8, 2020

Balancing Risk And Speed When Time Is Of The Essence: Proven Strategies To Accelerate Drug Development

By Cyrielle Corbin, Ph.D., Nadia Oueslati, Ph.D., Cyril Rols, Jiangli Yan, Ph.D., Muriel Richard and Marie-Gaelle Rogers

Risk

For an early-stage biotech, the decisions made now will shape the future of the company and can determine long-term success or failure. From day one, the pressure is on to rapidly progress towards milestones and demonstrate value to investors and other stakeholders. You need to move quickly and use resources efficiently to advance a drug candidate into the clinic and ultimately onto the market.

Biotech companies are faced with making a strategic assessment of how best to balance speed and risk and the impact of that decision. An experienced contract development and manufacturing organization (CDMO) can help guide you through the different stages of drug development and identify opportunities to accelerate timelines while ensuring that risk is properly mitigated, and quality is not compromised. In this ebook, we describe four areas of development where we have applied this strategy for customers.

VIEW THE E-BOOK!
Signing up provides unlimited access to:
Signing up provides unlimited access to:
  • Trend and Leadership Articles
  • Case Studies
  • Extensive Product Database
  • Premium Content
HELLO. PLEASE LOG IN. X

Not yet a member of BioProcess Online? Register today.

ACCOUNT SIGN UP X
Please fill in your account details
Login Information
I'm interested in newsletter subscriptions.
ACCOUNT SIGN UP

Subscriptions

Sign up for the newsletter that brings you the industry's latest news, technologies, trends and products.

You might also want to: